SEPN compared with RANI: revenue, margins and what each company keeps, and the suppliers and customers both name

SEPNSepterna, Inc.

Mkt capRevenueRevenue

RANIRani Therapeutics Holdings, Inc.

Mkt capRevenueRevenue

Compare

SEPNSepterna, Inc.

RANIRani Therapeutics Holdings, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only SEPN 2

VRTXVertex Pharmaceuticals Incorporated ("Vertex")customer

—Novounlistedcustomer

Shared 0

No shared counterparties.

Only RANI 6

—Celltrionunlistedsupplier

—Chugai Pharmaceuticalunlistedsupplier

—ProGenunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

—

ICL

unlistedsupplier

2 more · RANI chain ›

SEPNSepterna, Inc.

43.98· pre 43.98· delayed

Mkt cap$2.0BRevenue$27MQ2 FY26Revenue$46MFY25

RANIRani Therapeutics Holdings, Inc.

0.60· pre 0.60· delayed

Pre-marketOct 30 '26delayed

Mkt cap$82.2MRevenue$2MQ2 FY26Revenue—

Compare

Pre-marketOct 30 '26delayed

SEPNSepterna, Inc.

RANIRani Therapeutics Holdings, Inc.

43.98pre 43.98delayed

Price

0.60pre 0.60delayed

$2.0B

Mkt cap

$82.2M

Q2 FY26$27M

Revenue

$2MQ2 FY26

FY25$46M

Revenue

—

SEPN43.98vsRANI0.60Pre-marketOct 30 '26delayed